---
title: "Vagal Nerve Stimulator (VNS)"
ocid: "ocds-kuma6s-128705"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-kuma6s-128705"
markdown_url: "https://d3tenders.com/contract/ocds-kuma6s-128705.md"
json_url: "https://d3tenders.com/contract/ocds-kuma6s-128705.json"
source: "Sell2Wales"
current_stage: "Award"
buyer: "NWSSP CARDIFF AND VALE LOCAL HEALTH BOARD"
published: "2024-01-23"
---

# Vagal Nerve Stimulator (VNS)

Buyer: NWSSP CARDIFF AND VALE LOCAL HEALTH BOARD  
Current stage: Award  
OCID: ocds-kuma6s-128705

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-kuma6s-128705)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-kuma6s-128705.json)

## Summary

The NWSSP Cardiff and Vale Local Health Board has awarded a two-year contract for the supply of Vagal Nerve Stimulators (VNS) to LivaNova UK Ltd. The procurement stage was at the award phase, with the contract signed on 14th February 2023. The location of the procurement is Cardiff, UK, in the Health industry category. The Health Board opted for a limited procurement method without prior competition due to LivaNova's monopoly on VSN products, necessary for treating seizures.

This tender creating opportunities for business growth is suited for companies in the healthcare sector specialising in Vagal Nerve Stimulator technologies. As LivaNova UK Ltd holds a monopoly in this market, partnering with them for production and supply of VNS products could lead to significant business growth. The award of the contract signifies a potential for future collaborations in the Health industry, specifically in manufacturing specialised medical devices for therapeutic purposes.

## Notice

The Neurosciences department within Cardiff and Vale Local Health Board currently perform Vagal Nerve Stimulator (VNS) therapy. VNS therapy is delivered through an implanted device that sends mild pulses to the vagus nerve at regular intervals throughout the day in an effort to reduce and/or prevent seizures. Patients are referred to this type of therapy when drugs have failed to provide a more manageable treatment. These devices are programmable for a personalised therapy approach and the technology is highly specialised. Currently Livanova hold the monopoly of the global market for VSN products as they hold the patent for the manufacture and production of these stimulators, therefore the Health Board are proposing to award a two year contract.

### Procurement Information

Livanova hold the patent for VSN products and therefore have a monopoly of the global market. Due to this, the Health Board have no other option than to award a contract direct to Livanova UK Limited as these products are the only items that can reduce and/or prevent seizures for patients.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Sell2Wales |
| Latest notice | https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=128705 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 23 Jan 2024 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 14 Feb 2023 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £600,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NWSSP CARDIFF AND VALE LOCAL HEALTH BOARD |
| Locality | CARDIFF |
| Post town | Cardiff |
| Postcode | CF14 4HH |
| Country | Wales |
| ITL 1 | TLL Wales |
| ITL 2 | TLL5 South East Wales |
| ITL 3 | TLL52 Cardiff and Vale of Glamorgan |
| Local authority | Cardiff |
| Electoral ward | Heath |
| Westminster constituency | Cardiff North |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | LIVANOVA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33158210 - Stimulator

## Release History

- 23 Jan 2024 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=128705
- 14 Feb 2023 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=128705

## Documents

- https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=FEB427812
  Vagal Nerve Stimulator (VNS) - The Neurosciences department within Cardiff and Vale Local Health Board currently perform Vagal Nerve Stimulator (VNS) therapy. VNS therapy is delivered through an implanted device that sends mild pulses to the vagus nerve at regular intervals throughout the day in an effort to reduce and/or prevent seizures. Patients are referred to this type of therapy when drugs have failed to provide a more manageable treatment. These devices are programmable for a personalised therapy approach and the technology is highly specialised. Currently Livanova hold the monopoly of the global market for VSN products as they hold the patent for the manufacture and production of these stimulators, therefore the Health Board are proposing to award a two year contract.
- https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=JAN464273
  Vagal Nerve Stimulator (VNS) - The Neurosciences department within Cardiff and Vale Local Health Board currently perform Vagal Nerve Stimulator (VNS) therapy. VNS therapy is delivered through an implanted device that sends mild pulses to the vagus nerve at regular intervals throughout the day in an effort to reduce and/or prevent seizures. Patients are referred to this type of therapy when drugs have failed to provide a more manageable treatment. These devices are programmable for a personalised therapy approach and the technology is highly specialised. Currently Livanova hold the monopoly of the global market for VSN products as they hold the patent for the manufacture and production of these stimulators, therefore the Health Board are proposing to award a two year contract.

## Notice URLs

- http://nwssp.nhs.wales/ourservices/procurement-services/
- https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-128705

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-kuma6s-128705. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-kuma6s-128705.json.